©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 110617
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.110617
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.110617
Figure 3 Cholecystokinin-8 assay for cytotoxicity of DAF-FM probe.
A: Absorbance values at 490 nm of esophageal cancer cells treated with different concentrations of DAF-FM (0 μM: 1.28 ± 0.05; 50 μM: 1.05 ± 0.04); B: Cell survival rate-concentration curve (control group: 100% ± 2.1%, 50 μM group: 82.3% ± 4.1%). Data are expressed as mean ± SD, n = 6 replicate wells per group, P < 0.05 vs control group.
- Citation: Chen WH, Cai CF, Gao BZ, Hong WS, Xu YZ, Cai WJ. Visual screening and efficacy evaluation of high-performance fluorescent probe DAF-FM in esophagitis cancer transformation. World J Gastrointest Surg 2025; 17(12): 110617
- URL: https://www.wjgnet.com/1948-9366/full/v17/i12/110617.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i12.110617